Prevalence and Dynamics of BCR-ABL Independent Gene Mutations in Chronic Phase CML Patients

被引：0
|
作者：
Ruppert, Lioba [1 ]
Rinke, Jenny [1 ]
Waldau, Anja [1 ]
Pfirrmann, Markus [2 ]
Hochhaus, Andreas [1 ]
Ernst, Thomas [1 ]
机构：
[1] Univ Klinikum Jena, Klin Innere Med 2, Onkol Forschungslab, Jena, Germany
[2] Ludwig Maximilians Univ Munchen, Inst Med Informat Verarbeitung Biometrie & Epidem, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
486
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [1] Prevalence and dynamics of BCR-ABL independent gene mutations in chronic phase CML patients
    Ruppert, L.
    Rinke, J.
    Waldau, A.
    Hochhaus, A.
    Ernst, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 238 - 239
  • [2] Prevalence and Dynamics of BCR-ABL Independent Gene Mutations in Patients with Chronic Myeloid Leukemia
    Ernst, Thomas
    Rinke, Jenny
    Busch, Melinda
    Ernst, Jana
    Obstfelder, Ellen
    Schmidt, Mathias
    Schafer, Vivien
    Waldau, Anja
    Winkelmann, Nils
    Gruhn, Bernd
    Hochhaus, Andreas
    BLOOD, 2016, 128 (22)
  • [3] Dynamics of BCR-ABL independent gene mutations in patients with chronic myeloid leukemia
    Obstfelder, E.
    Rinke, J.
    Schmidt, M.
    Schaefer, V.
    Waldau, A.
    Winkelmann, N.
    Hochhaus, A.
    Ernst, T.
    Oncology Research and Treatment, 2015, 38 : 188 - 189
  • [4] BCR-ABL independent gene mutations in patients with chronic myeloid leukemia
    Schmidt, M.
    Rinke, J.
    Schaefer, V.
    Ziermann, J.
    Eigendorff, E.
    Hochhaus, A.
    Ernst, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 210 - 210
  • [5] PREVALENCE OF BCR-ABL IMATINIB RESISTANT MUTATIONS IN PORTUGUESE CHRONIC MYELOID LEUKAEMIA (CML) PATIENTS
    Palmeiro, A.
    Torres, F.
    Lemos, R.
    Teixeira, M.
    Gabriel, H.
    Rendeiro, P.
    Tavares, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 539 - 539
  • [6] INDIVIDUAL EARLY DYNAMICS OF BCR-ABL TRANSCRIPTS, BUT NOT BCR-ABL TRANSCRIPT LEVELS AT BASELINE PREDICT SURVIVAL IN PATIENTS WITH CHRONIC PHASE CML
    Shlyakhto, V.
    Hanfstein, B.
    Lauseker, M.
    Erben, P.
    Saussele, S.
    Fabarius, A.
    Proetel, U.
    Schnittger, S.
    Kolb, H.
    Krause, S.
    Schubert, J.
    Einsele, H.
    Haenel, M.
    Dengler, J.
    Falge, C.
    Kanz, L.
    Neubauer, A.
    Kneba, M.
    Stegelmann, F.
    Pfreundschuh, M.
    Waller, C.
    Spiekermann, K.
    Baerlocher, G.
    Pfirrmann, M.
    Hasford, J.
    Hofmann, W.
    Hehlmann, R.
    Hochhaus, A.
    Mueller, M.
    HAEMATOLOGICA, 2013, 98 : 453 - 454
  • [7] Identification Of Mutations In Bcr-Abl Gene In Newly Diagnosed Indian Patients With Chronic Myelogenous Leukemia (CML)
    Shyam, Aggarwal
    Verma, Binuja
    Vyas, Bijal
    Jauhri, Mayank
    BLOOD, 2013, 122 (21)
  • [8] Analysis of mutations in the BCR-ABL TK domain in CML patients
    Nesslboeck, M.
    Preuner, S.
    Lion, T.
    KLINISCHE PADIATRIE, 2010, 222 (03): : 217 - 217
  • [9] BCR-ABL independent gene mutations in children and adolescents with chronic myeloid leukemia
    Busch, M.
    Rinke, J.
    Schaefer, V
    Waldau, A.
    Ernst, J.
    Hochhaus, A.
    Gruhn, B.
    Ernst, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 53 - 54
  • [10] RESPONSE TO NILOTINIB IN CHRONIC MYELOGENOUS LEUKEMIA PATIENTS IN CHRONIC PHASE (CML-CP) ACCORDING TO BCR-ABL MUTATIONS AT BASELINE
    Radich, J.
    Kim, D. -W
    Martinelli, G.
    Soverini, S.
    Branford, S.
    Mueller, M.
    Haque, A.
    Shou, Y.
    Hochhaus, A.
    Hughes, T.
    Saglio, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 55 - 55
12345